|
Originally published In Press as doi:10.1074/jbc.M207414200 on September 26, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47022-47027, December 6, 2002
Specific Activation of Human Interleukin-5 Depends on de
Novo Synthesis of an AP-1 Complex*
Gretchen T. F.
Schwenger §,
Chee Choy
Kok ,
Estri
Arthaningtyas ,
Marc A.
Thomas¶,
Colin J.
Sanderson , and
Viatcheslav A.
Mordvinov**
From the Western Australian Institute for Medical
Research and the School of Biomedical Sciences, Curtin University of
Technology, Perth, Western Australia 6000, Australia
¶ Institut de Pharmacologie and Toxicologie,
Université de Lausanne, CH-1005 Switzerland, and
** Universite Libre de Bruxelles, Faculte de Medecine,
Laboratoire d'Immunologie experimentale, CP615, 808 Route de Lennik,
B1070 Brussels, Belgium
It is clear from the biology of eosinophilia that
a specific regulatory mechanism must exist. Because interleukin-5 (IL5) is the key regulatory cytokine, it follows that a gene-specific control
of IL5 expression must exist that differs even from closely related
cytokines such as IL4. Two features of IL5 induction make it unique
compared with other cytokines; first, induction by cyclic adenosine
monophosphate (cAMP), which inhibits other T-cell-derived cytokines,
and second, sensitivity to protein synthesis inhibitors, which have no
effect on other cytokines. This study has utilized the activation of
different transcription factors by different stimuli in a human T-cell
line to study the role of conserved lymphokine element 0 (CLE0) in the
specific induction of IL5. In unstimulated cells the ubiquitous Oct-1
binds to CLE0. Stimulation induces de novo synthesis of the
AP-1 members JunD and Fra-2, which bind to CLE0. The amount of IL5
produced correlates with the production of the AP-1 complex, suggesting
a key role in IL5 expression. The formation of the AP-1 complex is
essential, but the rate-limiting step is the synthesis of AP-1,
especially Fra-2. This provides an explanation for the sensitivity of
IL5 to protein synthesis inhibitors and a mechanism for the specific
induction of IL5 compared with other cytokines.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Molecular Immunology
Group, Western Australian Institute for Medical Research, Level 5, MRF
Bldg., Rear 50 Murray St., Perth, Australia 6000. Tel.: 618-9224-0357;
Fax: 618-9224-0360; E-mail: gretchen@cyllene.uwa.edu.au.
Supported by a National Health and Medical Research Council of
Australia Fellowship.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Wang, M. F. Shannon, and I. G. Young
A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes
Int. Immunol.,
February 1, 2006;
18(2):
313 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Adiseshaiah, S. R. Papaiahgari, H. Vuong, D. V. Kalvakolanu, and S. P. Reddy
Multiple cis-Elements Mediate the Transcriptional Activation of Human fra-1 by 12-O-Tetradecanoylphorbol-13-acetate in Bronchial Epithelial Cells
J. Biol. Chem.,
November 28, 2003;
278(48):
47423 - 47433.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|